Analytical Data
-
Gene name
ETF1
- Application
-
Alternative Names
ETF1；ERF1；RF1；SUP45L1；Eukaryotic peptide chain release factor subunit 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P62495
-
Expression Region
2-437aa
-
AA Sequence
ADDPSAADR NVEIWKIKKL IKSLEAARGN GTSMISLIIP PKDQISRVAK MLADEFGTAS NIKSRVNRLS VLGAITSVQQ RLKLYNKVPP NGLVVYCGTI VTEEGKEKKV NIDFEPFKPI NTSLYLCDNK FHTEALTALL SDDSKFGFIV IDGSGALFGT LQGNTREVLH KFTVDLPKKH GRGGQSALRF ARLRMEKRHN YVRKVAETAV QLFISGDKVN VAGLVLAGSA DFKTELSQSD MFDQRLQSKV LKLVDISYGG ENGFNQAIEL STEVLSNVKF IQEKKLIGRY FDEISQDTGK YCFGVEDTLK ALEMGAVEIL IVYENLDIMR YVLHCQGTEE EKILYLTPEQ EKDKSHFTDK ETGQEHELIE SMPLLEWFAN NYKKFGATLE IVTDKSQEGS QFVKGFGGIG GILRYRVDFQ GMEYQGGDDE FFDLDDY
-
Molecular Weight
49 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ETF1, or Eukaryotic Translation Elongation Factor 1, is a pivotal protein involved in the translation process of eukaryotic cells, facilitating the elongation phase of protein synthesis by delivering aminoacyl-tRNAs to the ribosome. Given its crucial role in cellular metabolism and protein production, the study of ETF1 has garnered significant interest in both basic and applied research realms. Understanding the structural and functional aspects of ETF1 can provide insights into the intricacies of translational regulation and its impact on cellular physiology. Furthermore, ETF1 has potential implications in the development of therapeutic strategies for diseases linked to protein synthesis dysregulation, such as cancer and neurodegenerative disorders. By exploring the properties and mechanisms of ETF1, researchers aim to identify novel targets for drug development and to enhance biotechnological applications, including the production of recombinant proteins in industrial settings. Therefore, the ongoing investigation into ETF1 not only enriches our comprehension of fundamental biological processes but also paves the way for innovations in medicine and biotechnology.
